The in vivo model corroborated our in vitro findings, in that mice engrafted with REH-VR cells that were treated with pitavastatin showed decreased levels of human CD45+ ALL cells in the bone marrow as compared with control (vehicle-treated) mice. The gene discussed is PTPRC; the disease is acute lymphoblastic leukemia.